MBD5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.770800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.961800E-01
Normal-vs-Stage2
2.840200E-01
Normal-vs-Stage3
4.514300E-02
Normal-vs-Stage4
8.284000E-01
Stage1-vs-Stage2
3.171800E-01
Stage1-vs-Stage3
2.764400E-02
Stage1-vs-Stage4
4.660000E-01
Stage2-vs-Stage3
2.004400E-01
Stage2-vs-Stage4
1.355420E-01
Stage3-vs-Stage4
1.426040E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.633800E-01
Normal-vs-AfricanAmerican
7.868600E-01
Normal-vs-Asian
2.719200E-01
Caucasian-vs-AfricanAmerican
2.736800E-01
Caucasian-vs-Asian
4.896200E-01
AfricanAmerican-vs-Asian
2.669200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.817400E-01
Normal-vs-Female
2.922800E-01
Male-vs-Female
8.205400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.310800E-01
Normal-vs-Age(41-60Yrs)
6.663200E-01
Normal-vs-Age(61-80Yrs)
1.608840E-01
Normal-vs-Age(81-100Yrs)
9.395800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.103400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.845400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.433770E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.223250E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.012400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.769200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.921210E-01
Normal-vs-Daily Drinker
5.041700E-02
Normal-vs-Weekly Drinker
1.171840E-01
Normal-vs-Occasional Drinker
4.712600E-01
Normal-vs-Social Drinker
6.578400E-01
Non Drinker-vs-Daily Drinker
5.573600E-01
Non Drinker-vs-Weekly Drinker
7.938400E-01
Non Drinker-vs-Occasional Drinker
1.495610E-01
Non Drinker-vs-Social Drinker
1.363010E-01
Daily Drinker-vs-Weekly Drinker
7.992000E-01
Daily Drinker-vs-Occasional Drinker
3.026300E-02
Daily Drinker-vs-Social Drinker
3.814200E-02
Weekly Drinker-vs-Occasional Drinker
1.085760E-01
Weekly Drinker-vs-Social Drinker
1.224200E-01
Occasional Drinker-vs-Social Drinker
8.081800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.300400E-02
Normal-vs-Grade 2
6.676800E-03
Normal-vs-Grade 3
2.320600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.048200E-01
Grade 1-vs-Grade 3
3.637000E-01
Grade 1-vs-Grade 4
2.300400E-02
Grade 2-vs-Grade 3
5.811000E-01
Grade 2-vs-Grade 4
6.676800E-03
Grade 3-vs-Grade 4
2.320600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.860000E-02
Normal-vs-NonDiabetic
2.695400E-01
Diabetic-vs-NonDiabetic
1.387610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.940200E-01
Normal-vs-NoPancreatitis
2.366800E-01
Pancreatitis-vs-NoPancreatitis
8.735400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.057600E-01
Normal-vs-N1
3.234200E-01
N0-vs-N1
5.153800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.620800E-01
Normal-vs-TP53-NonMutant
4.145200E-01
TP53-Mutant-vs-TP53-NonMutant
5.545800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
